BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37676726)

  • 1. Evidence of a Sjögren's disease-like phenotype following COVID-19 in mice and humans.
    Shen Y; Voigt A; Goranova L; Abed M; Kleiner DE; Maldonado JO; Beach M; Pelayo E; Chiorini JA; Craft WF; Ostrov DA; Ramiya V; Sukumaran S; Brown AN; Hanrahan KC; Tuanyok A; Warner BM; Nguyen CQ
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37676726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a Sjögren's disease-like phenotype following COVID-19.
    Shen Y; Voigt A; Goranova L; Abed M; Kleiner DE; Maldonado JO; Beach M; Pelayo E; Chiorini JA; Craft WF; Ostrov DA; Ramiya V; Sukumaran S; Tuanyok A; Warner BM; Nguyen CQ
    medRxiv; 2022 Oct; ():. PubMed ID: 36324812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
    Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
    Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.
    McCoy SS; Parker M; Gurevic I; Das R; Pennati A; Galipeau J
    Rheumatology (Oxford); 2022 Oct; 61(10):4207-4218. PubMed ID: 35218354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Hepatitis D Virus in Minor Salivary Gland of Sjögren's Disease.
    Hesterman MC; Furrer SV; Fallon BS; Weller ML
    J Dent Res; 2023 Oct; 102(11):1272-1279. PubMed ID: 37575047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vimentin antibodies are associated with higher severity of Sjögren's disease.
    Bagavant H; Araszkiewicz AM; Rasmussen A; Pezant N; Montgomery C; Scofield RH; Farris D; Lessard CJ; Deshmukh US
    Clin Immunol; 2023 Feb; 247():109243. PubMed ID: 36702181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
    Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
    PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients.
    Apostolou E; Moustardas P; Iwawaki T; Tzioufas AG; Spyrou G
    Front Immunol; 2019; 10():506. PubMed ID: 30967862
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?
    Baldini C; Berardicurti O; Giacomelli R; Bombardieri M
    Autoimmun Rev; 2024 Jan; 23(1):103425. PubMed ID: 37634677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study.
    McCoy SS; Hetzel S; VanWormer JJ; Bartels CM
    Clin Rheumatol; 2022 Oct; 41(10):3065-3074. PubMed ID: 35701626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
    Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
    Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
    Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
    J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
    Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA
    Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.
    Szczerba BM; Kaplonek P; Wolska N; Podsiadlowska A; Rybakowska PD; Dey P; Rasmussen A; Grundahl K; Hefner KS; Stone DU; Young S; Lewis DM; Radfar L; Scofield RH; Sivils KL; Bagavant H; Deshmukh US
    Ann Rheum Dis; 2016 Mar; 75(3):617-22. PubMed ID: 25906316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
    Haga HJ
    J Rheumatol; 2002 Feb; 29(2):305-8. PubMed ID: 11838847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.